Clinical safety and tolerance of mitoxantrone (Novantrone).
D000880:Anthraquinones / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004361:Drug Tolerance; D005260:Female; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D007364:Intercalating Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008942:Mitoxantrone; D012306:Risk; D013318:Stroke Volume / Q000187:drug effects; D013997:Time Factors
D000880:Anthraquinones; D000970:Antineoplastic Agents; D007364:Intercalating Agents; D008942:Mitoxantrone